dipeptidyl peptidase-4 (DPP-4) inhibitors. These drugs are designed to lower blood glucose by blocking the breakdown of incretins, which are hormones released in the stomach that increase insulin secretion in response to food. High incretin levels stimulate insulin release; however, this insulin response is not sustained and therefore these drugs do not cause weight gain. The risk of hypoglycemia is also low.
